Life Sciences & Chemistry
Start-up = challenge? Let’s tackle it together!
Are you a founder in the field of life science and chemistry and on the lookout for financing? At HTGF, we not only offer you investment know-how, but also understand your specific needs and provide you with the right expertise to support your business ideas. We leverage our tailored network to help you achieve success.
Many steps must be taken to become a successful start-up
Our Life Sciences & Chemistry team has the required start-up spirit! We have both entrepreneurial expertise and an understanding of science, medicine and practical applications. Having invested in over 200 life science and chemical companies since 2005, we know what really matters.
With our expertise and passion, we are at your side as a sparring partner from seed to exit – whether it be in the field of drug development and biotech, medtech and diagnostics, digital health, R&D tools or chemistry.
The right tools
We offer you the right tools to meet your individual challenges as a founder of a life sciences and chemical start-up:
We help you get started
- Fast and flexible seed financing
- Matching with co-investors from our international network
- Communication on an equal footing
- Inspiration and knowledge transfer
Let’s develop and grow together
- Support in the acquisition of follow-up financing
- Exchanges with founders and our partners from research, industry and SMEs
- Close connection with cooperation partners
A shared path – from seed to exit
- Support in finding the most suitable M&A advisors
- Support in negotiations and due diligence
- Assistance with company valuations and incentives
- Transaction security from trade sale to IPO
- Access to the HTGF network with many potential buyers
Who we are
Life Sciences & Chemistry Team
Dr. Angelika Vlachou
Partner
Dr. Bernd Goergen
Partner
Marco Winzer
Partner
Dr. Anke Caßing
Principal / Authorized Signatory
Dr. Caroline Fichtner
Principal / Authorized Signatory
Kay G. Balster
Principal / Authorized signatory
Dr. Frank Hensel
Principal / Authorized signatory
Dr. Christian Kannemeier
Senior Investment Manager
Dr. Nikolaus Raupp
Senior Investment Manager
Niels Sharman
Senior Investment Manager
Dr. Natalya Baltrukovich
Investment Manager
Ulrike Kalapis
Investment Manager
Dr. Laura Pedroza
Investment Manager
Dr. Lena-Sophie Schütter
Investment Manager
Dr. Katharina Severin
Investment Manager
Dr. Jan Engels
Investment Manager
Tilmann Petersen
Investment Manager
Dr. Andrei Miclea
Investment Analyst
Leonard Trappe
Junior Analyst
What you can expect from us
- From the very early stage to the exit, we support you as partners with our know-how and understanding of your needs.
- We have an entrepreneurial spirit – many of us have founded our own companies and we have the necessary appetite for risk
- We understand how financing works and can call on our network
- We have backgrounds as scientists and know the pitfalls: manufacturing/CMC, regulatory affairs, market access, team growth, business development, etc.
The areas we invest in include:
Pharma/biotech
Medtech
R&D tools
Diagnostics
Digital health
Chemistry
Our Life Sciences & Chemistry Portfolio
Let’s turn ideas into reality!
Societal challenges, such as diseases or advancing climate change, require innovative solutions. And this is why pioneering start-ups in the fields of life sciences and healthcare, chemistry, food and agricultural technology, and new materials are playing a crucial role.
Germany has the platform to continue launching successful high-tech start-ups:
- Top-class research at universities and institutes
- Close cooperation between industry and consumers
- Transfer-enabling support
With your innovative start-up ideas, we can create sustainable and disruptive solutions together – what are we waiting for?
Looking to start a business? Contact our team here.
Is your pitch deck complete? Upload it here!
Topics that might interest you
HepaRegeniX raises €15 million Series C round to advance clinical development of HRX-215 for liver regeneration
Health Tech Start-up Carelane Raises €800,000 in Pre-Seed Funding to Revolutionize Clinical Trial Software
Cultimate Foods raises 2.3 million EUR seed funding from leading Biotech and Foodtech investors to revolutionize the alternative meat industry
Successful exit for HTGF: Novo Nordisk to acquire Cardior Pharmaceuticals
Tubulis Closes Upsized €128 Million Series B2 to Accelerate Clinical Development of Solid Tumor-Focused ADC Pipeline
